FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nicole Moins

Research Profile

Disorders

Living Beings

Chemicals & Drugs

Anatomy

Concepts & Ideas

Tissue Distribution

Procedures

Secondary Ion Mass Spectrometry

Co-author Network

Publications

TOP 3
Latifa Rbah-Vidal; Aurélien Vidal; Serge Askienazy; Laurent Audin; Philippe Auzeloux; Sophie Besse; Mathilde Bonnet; Florent Cachin; Françoise Degoul; Frédéric Dollé; Elisabeth Miot-Noirault; Nicole Moins; Jean-Michel Chezal
Early detection and longitudinal monitoring of experimental primary and disseminated melanoma using [¹⁰F]ICF01006, a highly promising melanoma PET tracer.
Maryline Gardette; Jean-Luc Guerquin-Kern; Pierre Labarre; Jean-Claude Madelmont; Elisabeth Miot-Noirault; Mathilde Bonnet; Jean-Michel Chezal; Nicolas Desbois; Janine Papon; Ting-Di Wu; Nicole Moins
Evaluation of new iodinated acridine derivatives for targeted radionuclide therapy of melanoma using 125I, an Auger electron emitter.
Aurélie Maisonial; Elisabeth Miot-Noirault; Nicole Moins; Janine Papon; Latifa RBAH-VIDAL; Bertrand Tavitian; Aurélien Vidal; Serge Askienazy; Philippe Auzeloux; Martine Bayle; Raphaël Boisgard; Mathilde Bonnet-Duquennoy; Michèle Borel; Frédéric Dollé; Marie-Josèphe Galmier; Bertrand Kuhnast; Jean-Claude Madelmont; Jean-Michel Chezal
Single photon emission computed tomography/positron emission tomography imaging and targeted radionuclide therapy of melanoma: new multimodal fluorinated and iodinated radiotracers.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nicole Moins (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Latifa Rbah-Vidal; Aurélien Vidal; Serge Askienazy; Laurent Audin; Philippe Auzeloux; Sophie Besse; Mathilde Bonnet; Florent Cachin; Françoise Degoul; Frédéric Dollé; Elisabeth Miot-Noirault; Nicole Moins; Jean-Michel Chezal
Early detection and longitudinal monitoring of experimental primary and disseminated melanoma using [¹⁰F]ICF01006, a highly promising melanoma PET tracer.
European journal of nuclear medicine and molecular imaging 2012;39(9):1449-61.
2011: Maryline Gardette; Jean-Luc Guerquin-Kern; Pierre Labarre; Jean-Claude Madelmont; Elisabeth Miot-Noirault; Mathilde Bonnet; Jean-Michel Chezal; Nicolas Desbois; Janine Papon; Ting-Di Wu; Nicole Moins
Evaluation of new iodinated acridine derivatives for targeted radionuclide therapy of melanoma using 125I, an Auger electron emitter.
Investigational new drugs 2011;29(6):1253-63.
2011: Aurélie Maisonial; Elisabeth Miot-Noirault; Nicole Moins; Janine Papon; Latifa RBAH-VIDAL; Bertrand Tavitian; Aurélien Vidal; Serge Askienazy; Philippe Auzeloux; Martine Bayle; Raphaël Boisgard; Mathilde Bonnet-Duquennoy; Michèle Borel; Frédéric Dollé; Marie-Josèphe Galmier; Bertrand Kuhnast; Jean-Claude Madelmont; Jean-Michel Chezal
Single photon emission computed tomography/positron emission tomography imaging and targeted radionuclide therapy of melanoma: new multimodal fluorinated and iodinated radiotracers.
Journal of medicinal chemistry 2011;54(8):2745-66.
2010: Fabien Rondepierre; Bernadette Bouchon; Mathilde Bonnet; Nicole Moins; Jean M Chezal; Michel D'Incan; Françoise Degoul
B16 melanoma secretomes and in vitro invasiveness: syntenin as an invasion modulator.
Melanoma research 2010;20(2):77-84.
2009: Elisabeth Miot-Noirault; Janine Papon; Marilyne Gardette; Mathilde Bonnet-Duquennoy; Pierre Labarre; Aurélie Maisonial; Jean-Claude Madelmont; Jean Maublant; Jean-Michel Chezal; Nicole Moins
The use of [(125)I] scintigraphic in vivo imaging in melanoma-bearing mice for a rapid prescreening of vectors to melanoma tissue.
Cancer biotherapy & radiopharmaceuticals 2009;24(5):629-36.
2009: Elisabeth Miot-Noirault; François Gouin; Aurélien Vidal; Maryse Rapp; Jean Maublant; Serge Askienazy; Jean-Michel Chezal; Dominique Heymann; Françoise Redini; Nicole Moins
First preclinical imaging of primary cartilage neoplasm and its local recurrence using 99mTc-NTP 15-5 radiotracer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(9):1541-7.
2009: Mathilde Bonnet-Duquennoy; Janine Papon; Florence Mishellany; Pierre Labarre; Jean-Luc Guerquin-Kern; Ting-Di Wu; Maryline Gardette; Jean Maublant; Frédérique Penault-Llorca; Elisabeth Miot-Noirault; Anne Cayre; Jean-Claude Madelmont; Jean-Michel Chezal; Nicole Moins
Targeted radionuclide therapy of melanoma: anti-tumoural efficacy studies of a new 131I labelled potential agent.
International journal of cancer. Journal international du cancer 2009;125(3):708-16.
2009: Michele Borel; Philippe Pastoureau; Janine Papon; Jean-Claude Madelmont; Nicole Moins; Jean Maublant; Elisabeth Miot-Noirault
Longitudinal profiling of articular cartilage degradation in osteoarthritis by high-resolution magic angle spinning 1H NMR spectroscopy: experimental study in the meniscectomized guinea pig model.
Journal of proteome research 2009;8(5):2594-600.
2009: Fabien Rondepierre; Bernadette Bouchon; Janine Papon; Mathilde Bonnet-Duquennoy; Roselyne Kintossou; Nicole Moins; Jean Maublant; Jean C Madelmont; Michel D'Incan; Françoise Degoul
Proteomic studies of B16 lines: involvement of annexin A1 in melanoma dissemination.
Biochimica et biophysica acta 2009;1794(1):61-9.
2008: Delphine Denoyer; Pierre Labarre; Janine Papon; Elisabeth Miot-Noirault; Marie-Josephe Galmier; Jean-Claude Madelmont; Jean-Michel Chezal; Nicole Moins
Development of a high-performance liquid chromatographic method for the determination of a new potent radioiodinated melanoma imaging and therapeutic agent.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2008;875(2):411-8.
2008: Elisabeth Miot-Noirault; Aurélien Vidal; Philippe Auzeloux; Jean-Claude Madelmont; Jean Maublant; Nicole Moins
First In Vivo SPECT Imaging of Mouse Femorotibial Cartilage Using 99mTc-NTP 15-5.
Molecular imaging 2008;7(6):263-71.
2008: Pierre Labarre; Janine Papon; Alison H Rose; Jean-Luc Guerquin-Kern; Laurence Morandeau; Ting-Di Wu; Marie-France Moreau; Martine Bayle; Jean-Michel Chezal; Alain Croisy; Jean-Claude Madelmont; Harvey Turner; Nicole Moins
Melanoma affinity in mice and immunosuppressed sheep of [(125)I]N-(4-dipropylaminobutyl)-4-iodobenzamide, a new targeting agent.
Nuclear medicine and biology 2008;35(7):783-91.
2008: Nicolas Desbois; Maryline Gardette; Janine Papon; Pierre Labarre; Aurélie Maisonial; Philippe Auzeloux; Claire Lartigue; Bernadette Bouchon; Eric Debiton; yves blache; Olivier Chavignon; Jean-Claude Teulade; Jean Maublant; Jean-Claude Madelmont; Nicole Moins; Jean-Michel Chezal
Design, synthesis and preliminary biological evaluation of acridine compounds as potential agents for a combined targeted chemo-radionuclide therapy approach to melanoma.
Bioorganic & medicinal chemistry 2008;16(16):7671-90.
2008: Jean-Michel Chezal; Janine Papon; Pierre Labarre; Claire Lartigue; Marie-Josephe Galmier; Caroline Decombat; Olivier Chavignon; Jean Maublant; Jean-Claude Teulade; Jean-Claude Madelmont; Nicole Moins
Evaluation of radiolabeled (hetero)aromatic analogues of N-(2-diethylaminoethyl)-4-iodobenzamide for imaging and targeted radionuclide therapy of melanoma.
Journal of medicinal chemistry 2008;51(11):3133-44.
2007: Elisabeth Miot-Noirault; Aurélien Vidal; Philippe Pastoureau; Jacques Bonafous; Agnès Chomel; Laurent Sarry; Laurent Audin; Jean-Claude Madelmont; Nicole Moins
Early detection and monitoring of cartilage alteration in the experimental meniscectomised guinea pig model of osteoarthritis by 99mTc-NTP 15-5 scintigraphy.
European journal of nuclear medicine and molecular imaging 2007;34(8):1280-90.
2005: Féras Chéhadé; Claire de Labriolle Vaylet; Nicole Moins; Marie-France Moreau; Janine Papon; Pierre Labarre; Pierre Galle; Annie Veyre; Elif Hindié
Secondary ion mass spectrometry as a tool for investigating radiopharmaceutical distribution at the cellular level: the example of I-BZA and (14)C-I-BZA.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(10):1701-6.
2005: Sandrine Mansard; Janine Papon; Marie-France Moreau; Elisabeth Miot-Noirault; Pierre Labarre; Martine Bayle; Annie Veyre; Jean-Claude Madelmont; Nicole Moins
Uptake in melanoma cells of N-(2-diethylaminoethyl)-2-iodobenzamide (BZA2), an imaging agent for melanoma staging: relation to pigmentation.
Nuclear medicine and biology 2005;32(5):451-8.
2005: Marie-France Moreau; Janine Papon; Pierre Labarre; Nicole Moins; Michèle Borel; Martine Bayle; Bernadette Bouchon; Jean-Claude Madelmont
Synthesis, in vitro binding and biodistribution in B16 melanoma-bearing mice of new iodine-125 spermidine benzamide derivatives.
Nuclear medicine and biology 2005;32(4):377-84.
2005: Michèle Borel; David Lafarge; Marie-France Moreau; Martine Bayle; Laurent Audin; Nicole Moins; Jean-Claude Madelmont
High resolution magic angle spinning NMR spectroscopy used to investigate the ability of drugs to bind to synthetic melanin.
Pigment cell research / sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society 2005;18(1):49-54.
2004: Elisabeth Miot-Noirault; Jean Legault; Florent Cachin; Emmanuelle Mounetou; Françoise Degoul; René C Gaudreault; Nicole Moins; Jean-Claude Madelmont
Antineoplastic potency of arylchloroethylurea derivatives in murine colon carcinoma.
Investigational new drugs 2004;22(4):369-78.
2004: I Sillaire-Houtmann; Jacques Bonafous; Annie Veyre; Danièle Mestas; Michel D'Incan; Nicole Moins; Jean-Louis Kemeny; Florence Chossat; Franck Bacin
[Phase 2 clinical study of 123I-N-(2-diethylaminoethyl)-2-iodobenzamide in the diagnostic of primary and metastatic ocular melanoma].
Journal français d'ophtalmologie 2004;27(1):34-9.
2002: Nicole Moins; Michel D'Incan; Jacques Bonafous; Franck Bacin; Pierre Labarre; Marie-France Moreau; Danièle Mestas; Elisabeth Noirault; Florence Chossat; Eric Berthommier; Janine Papon; Martine Bayle; Pierre Souteyrand; Jean-Claude Madelmont; Annie Veyre
123I-N-(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging.
European journal of nuclear medicine and molecular imaging 2002;29(11):1478-84.
2002: Pierre Labarre; Janine Papon; Marie-France Moreau; Nicole Moins; Martine Bayle; Annie Veyre; Jean-Claude Madelmont
Melanin affinity of N-(2-diethylaminoethyl)-4-iodobenzamide, an effective melanoma imaging agent.
Melanoma research 2002;12(2):115-21.
2001: Nicole Moins; Janine Papon; H Seguin; Daniel Gardette; Marie-France Moreau; Pierre Labarre; Martine Bayle; J Michelot; Jean Claude Gramain; Jean-Claude Madelmont; Annie Veyre
Synthesis, characterization and comparative biodistribution study of a new series of p-iodine-125 benzamides as potential melanoma imaging agents.
Nuclear medicine and biology 2001;28(7):799-808.
2001: F Chehade; Claire de Labriolle Vaylet; J Michelot; Nicole Moins; Marie-France Moreau; Elif Hindié; Janine Papon; Françoise Escaig; Pierre Galle; Annie Veyre
Distribution of I-BZA (N-2-diethylaminoethyl-4-iodobenzamide) in grafted melanoma and normal skin: a study by secondary ion mass spectroscopy.
Cellular and molecular biology (Noisy-le-Grand, France) 2001;47(3):529-34.
2000: P Bonicel; J Michelot; Franck Bacin; Janine Papon; Jean-Louis Kemeny; Nicole Moins; Daniel Morvan; Jean-Claude Madelmont
Establishment of IPC 227 cells as human xenografts in rabbits: a model of uveal melanoma.
Melanoma research 2000;10(5):445-50.
2000: Nicole Moins; Anne Cayre; Sylvie Chevillard; Jean Maublant; Pierre Verrelle; Françoise Finat-Duclos
Effects of MDR reversing agent combinations on the 3H-daunomycin accumulation in drug-sensitive and drug-resistant human cancer cells.
Anticancer research 2000;20(4):2617-23.
1999: Pierre Labarre; Janine Papon; Marie-France Moreau; Nicole Moins; Annie Veyre; Jean-Claude Madelmont
Evaluation in mice of some iodinated melanoma imaging agents using cryosectioning and multi-wire proportional counting.
European journal of nuclear medicine 1999;26(5):494-8.
1999: Anne Cayre; Nicole Moins; Françoise Finat-Duclos; Jean Maublant; Pierre Verrelle
Comparative 99mTc-sestamibi and 3H-daunomycin uptake in human carcinoma cells: relation to the MDR phenotype and effects of reversing agents.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(4):672-6.
1998: Lionel Camilleri; Nicole Moins; M Mouchonière; M Renoux; P Bailly; Annie Veyre; Jean Maublant; Charles De Riberolles
Cultured neonatal rat cardiomyocytes and 99mTc-sestamibi to assess the direct effects of cardioplegia.
Cardiovascular surgery (London, England) 1998;6(6):614-21.
1997: Anne Cayre; Nicole Moins; Françoise Finat-Duclos; Pierre Verrelle; Jean Maublant
Comparison between technetium-99m-sestamibi and hydrogen-3-daunomycin myocardial cellular retention in vitro.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(11):1674-7.
1997: Lionel Camilleri; Nicole Moins; Janine Papon; Jean Maublant; P Bailly; Charles De Riberolles; Annie Veyre
Validity of a model of cultured myocardial cells for assessment of cardioplegia.
Cell biology and toxicology 1997;13(6):435-44.
1996: Anne Cayre; Nicole Moins; Françoise Finat-Duclos; Jean Maublant; E Albuisson; Pierre Verrelle
In vitro detection of the MDR phenotype in rat myocardium: use of PCR, [3H]daunomycin and MDR reversing agents.
Anti-cancer drugs 1996;7(8):833-7.
1995: Marie-France Moreau; J Michelot; Janine Papon; M Bayle; Pierre Labarre; Jean-Claude Madelmont; D Parry; Jean-Yves Boire; Nicole Moins; H Seguin
Synthesis, radiolabeling, and preliminary evaluation in mice of some (N-diethylaminoethyl)-4-iodobenzamide derivatives as melanoma imaging agents.
Nuclear medicine and biology 1995;22(6):737-47.
1993: Jean Maublant; Nicole Moins; P Gachon; M Renoux; Z Zhang; Annie Veyre
Uptake of technetium-99m-teboroxime in cultured myocardial cells: comparison with thallium-201 and technetium-99m-sestamibi.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1993;34(2):255-9.
1991: Nicole Moins; M Renoux; M Boucher; P Gachon
Paradoxal pharmacologic effects observed with beta-blocker agents on cardiac cells in culture.
In vitro cellular & developmental biology : journal of the Tissue Culture Association 1991;27A(2):147-50.
1989: Jean Maublant; Nicole Moins; P Gachon
Uptake and release of two new Tc-99m labeled myocardial blood flow imaging agents in cultured cardiac cells.
European journal of nuclear medicine 1989;15(4):180-2.
1988: Jean Maublant; P Gachon; Nicole Moins
Hexakis (2-methoxy isobutylisonitrile) technetium-99m and thallium-201 chloride: uptake and release in cultured myocardial cells.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1988;29(1):48-54.
1987: Jean Maublant; Nicole Moins; E A Van Royen; Jean-René Lusson; Jean Cassagnes; Annie Veyre; P Gachon
Myocardial uptake of thallium-201 diethyldithiocarbamate (201T1-DDC) in cultured heart cells and in humans.
European journal of nuclear medicine 1987;13(8):408-9.
1986: F Chollet-Debord; Nicole Moins; P Gachon; P Duchene-Marullaz
Comparison of verapamil and bepridil, two slow channel inhibitors, in protection against calcium-induced arrhythmias.
Naunyn-Schmiedeberg's archives of pharmacology 1986;334(1):105-9.
1986: F Chollet-Debord; Nicole Moins; M Renoux; P Gachon
Effects of the ionophore grisorixin on myocardial function and metabolism in isolated perfused working rat heart under normoxic and hypoxic conditions.
Canadian journal of physiology and pharmacology 1986;64(5):631-40.
1986: P Gachon; Nicole Moins; Jean Maublant; M R Ross; W D Davidson; I Mena
Relationship between 201Tl uptake and oxidative metabolism in cultured myocardial cells.
Nuclear medicine communications 1986;7(1):59-64.
1985: Jean Maublant; Nicole Moins; P Gachon; M R Ross; W D Davidson; I Mena
Effects of grisorixin on the distribution of thallium-201 and on the oxidative metabolism in cultured myocardial cells.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1985;26(6):626-9.
1983: Nicole Moins; P Gachon; Jean Maublant; P Duchêne-Marullaz
Comparative study of vascular effects of four calcium antagonists using a multi-organ functional imaging technique with thallium-201.
Journal of cardiovascular pharmacology 1983;5(6):978-82.
1983: Jean Maublant; P Gachon; Nicole Moins; P Duchene-Marullaz
Quantification of infarct size in the dog by thallium-201 single photon emission transaxial tomography (SPETT).
European heart journal 1983;4(4):272-9.
1983: P Duchêne-Marullaz; Nicole Moins; P Gachon; M Boucher; Jean Maublant
Effects of pindolol on the heart rate in the conscious dog with chronic atrioventricular block and the distribution of blood mass in the anesthetized dog.
Journal de pharmacologie 1983;14 Suppl 2():11-6.
1982: Nicole Moins; P Gachon; Jean Maublant; P Duchene-Marullaz
Hemodynamic effects of grisorixin, a monocarboxylic ionophore.
Archives internationales de pharmacodynamie et de thérapie 1982;260(1):104-14.
1982: P Gachon; Nicole Moins; Jean Maublant
Multi-organ functional imaging with thallium-201: a new noninvasive method for rapid assessment of vasoactive drugs.
Journal of pharmacological methods 1982;8(3):213-23.
1982: Nicole Moins; P Gachon; Jean Maublant
Myocardial imaging in dogs treated with grisorixin: relationship between thallium-201 uptake and coronary blood flow.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1982;23(4):330-6.
1981: Jean Maublant; Nicole Moins; P Gachon
Assessment of drugs by functional imaging of thallium-201 distribution in the dog.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1981;22(10):921-4.
1980: Jean Maublant; P Gachon; Nicole Moins; M Jourde; P Duchêne-Marullaz
Myocardial imaging in dogs with thallium-201 and the ionophore grisorixin.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1980;21(8):787-9.
1980: P Gachon; Nicole Moins
The cardiovascular effects of two monocarboxylic inophores, grisorixin and alborixin, in anesthetized guinea-pigs.
Arzneimittel-Forschung 1980;30(9):1502-7.